TherapeuticsMD Inc (NASDAQ:TXMD)

3.69
Delayed Data
As of Sep 16
 +0.27 / +7.89%
Today’s Change
1.82
Today|||52-Week Range
6.94
-3.15%
Year-to-Date
Here's Why TherapeuticsMD Jumped 34% in August
Sep 04 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.42
Today’s open3.40
Day’s range3.38 - 3.72
Volume3,542,555
Average volume (3 months)3,498,545
Market cap$825.0M
Data as of 4:00pm ET, 09/16/2019

Growth & Valuation

Earnings growth (last year)-59.27%
Earnings growth (this year)-27.36%
Earnings growth (next 5 years)+19.60%
Revenue growth (last year)-4.04%
P/E ratioNM
Price/Sales53.25
Price/Book8.43

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.25+1.91%
KURAKura Oncology Inc+0.32+2.00%
QTRXQuanterix Corp-0.60-2.31%
GNFTGenfit SA+0.76+4.42%
Data as of 4:00pm ET, 09/16/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$16.1M
Annual profit (last year)-$132.6M
Net profit margin-823.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts